No black box warning on record for Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol

As of the latest FDA labeling reviewed, Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol (DICLOFENAC SODIUM/MISOPROSTOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity with NSAIDs : Use of NSAIDs, including diclofenac in women at about 20 weeks gestation and later in pregnancy may cause oligohydramnios/fetal renal dysfunction and premature closure of the fetal ductus arteriosus. ( 4 , 5.1 , 8.1 ) Hepatotoxicity: Inform patients of warning signs and symptoms of hepatotoxicity. Discontinue if abnormal liver tests pe

No black box warning on record for Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity with NSAIDs : Use of NSAIDs, including diclofenac in women at about 20 weeks gestation and later in pregnancy may cause oligohydramnios/fetal renal dysfunction and premature closure of the fetal ductus arteriosus. ( 4 , 5.1 , 8.1 ) Hepatotoxicity: Inform patients of warning signs and symptoms of hepatotoxicity. Discontinue if abnormal liver tests pe

Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol Black Box Warning

No black box warning on record for Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol

Other warnings & precautions

Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol Black Box Warning

No black box warning on record for Diclofenac Sodium/misoprostol Diclofenac-Sodium-Misoprostol

Other warnings & precautions